ROHM’s three-phase motor driver implements proprietary control technology to significantly reduce motor power consumption by ...

The EPC9196 has been validated in real-world conditions, powering a 3-kW servo motor at 150 VDC and 60 kHz switching ...

Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...

Reflex Drive, a deep-tech startup from India, has selected power devices from Technologies AG for its next-generation motor control solutions for unmanned aerial vehicles (UAVs). By integrating ...

The VIA series of isolation amplifiers are developed to deliver outstanding thermal stability and precise measurement capabilities. With a typical CMTI of 150kV/μs, these amplifiers deliver robust ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

June 11, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ('Thiogenesis' or the 'Company') a clinical-stage biotechnology company developing disulfides that drive the production of ...

Achieves FDA Alignment on CMC and Non-Clinical Toxicology Regulatory Path for Nebokitug in PSC— —Preparations for the Nebokitug PSC Phase 3 Clinical Trial Advance as Discussions with Potential ...

The FDA has accepted for review the resubmitted NDA for ND0612 for the treatment of motor fluctuations in patients with Parkinson disease.

Sanofi is banking on the totality of data from the three phase 3 trials supporting potential filings for tolebrutinib, with the HERCULES result backed up by secondary endpoint data from the GEMINI ...

Researchers have succeeded in constructing the coil of an electric motor using only carbon nanotubes without any metals, and ...

Funding Dedicated to Building and Protecting Motorized Access Across the U.S., With Focus on Oregon and Georgia Yamaha ...